 Straits Times |
Roche drugs, chemo destroy 46 percent of breast tumors
Reuters LOS ANGELES (Reuters) – Combining experimental antibody drug pertuzumab with Herceptin, an antibody first approved in 1998, and chemotherapy shrank tumors in nearly half of newly diagnosed breast cancer patients treated in a clinical trial. … Breast cancer drug combo shows promise: study Genentech breathes new life into failed breast cancer drug Drug combo helps women with early breast cancer |
View full post on Health – Google News
